Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ingrid Pabinger

Showing results (11-20 of 367) with videos related to

Pageof 37
Sort By:
Obstetrics and Gynecology|March 21, 2009
Anti-factor xa plasma levels in pregnant women receiving low molecular weight heparin thromboprophylaxisIngrid Pabinger, Andreas Greinacher
Lancet (London, England)|February 24, 2009
Eltrombopag in chronic idiopathic thrombocytopenic purpuraSimon Panzer, Ingrid Pabinger
Wiener Klinische Wochenschrift|September 19, 2003
Pregnancy-associated thrombosisIngrid Pabinger, Helga Grafenhofer
Pathophysiology of Haemostasis and Thrombosis|September 19, 2003
Thrombosis during pregnancy: risk factors, diagnosis and treatmentIngrid Pabinger, Helga Grafenhofer
Blood|November 8, 2019
How I treat patients with hereditary antithrombin deficiencyIngrid Pabinger, Johannes Thaler
Hematology. American Society of Hematology. Education Program|December 10, 2017
Direct oral anticoagulants: now also for prevention and treatment of cancer-associated venous thromboembolism?Ingrid Pabinger, Julia Riedl
Hamostaseologie|June 15, 2012
[Tumor and thrombosis]Cihan Ay, Ingrid Pabinger
The Lancet. Haematology|September 18, 2017
Is oral all-trans retinoic acid plus danazol a refinement of second-line therapy for primary immune thrombocytopenia in adults?Simon Panzer, Ingrid Pabinger
Thrombosis Research|June 12, 2012
Predictive potential of haemostatic biomarkers for venous thromboembolism in cancer patientsCihan Ay, Ingrid Pabinger
Hematology. American Society of Hematology. Education Program|February 20, 2015
Flamethrowers: blood cells and cancer thrombosis riskIngrid Pabinger, Florian Posch
Pageof 37

Showing results (11-20 of 367) with videos related to

Sort By:
Pageof 37
Obstetrics and Gynecology|March 21, 2009
Anti-factor xa plasma levels in pregnant women receiving low molecular weight heparin thromboprophylaxisIngrid Pabinger, Andreas Greinacher
Lancet (London, England)|February 24, 2009
Eltrombopag in chronic idiopathic thrombocytopenic purpuraSimon Panzer, Ingrid Pabinger
Wiener Klinische Wochenschrift|September 19, 2003
Pregnancy-associated thrombosisIngrid Pabinger, Helga Grafenhofer
Pathophysiology of Haemostasis and Thrombosis|September 19, 2003
Thrombosis during pregnancy: risk factors, diagnosis and treatmentIngrid Pabinger, Helga Grafenhofer
Blood|November 8, 2019
How I treat patients with hereditary antithrombin deficiencyIngrid Pabinger, Johannes Thaler
Hematology. American Society of Hematology. Education Program|December 10, 2017
Direct oral anticoagulants: now also for prevention and treatment of cancer-associated venous thromboembolism?Ingrid Pabinger, Julia Riedl
Hamostaseologie|June 15, 2012
[Tumor and thrombosis]Cihan Ay, Ingrid Pabinger
The Lancet. Haematology|September 18, 2017
Is oral all-trans retinoic acid plus danazol a refinement of second-line therapy for primary immune thrombocytopenia in adults?Simon Panzer, Ingrid Pabinger
Thrombosis Research|June 12, 2012
Predictive potential of haemostatic biomarkers for venous thromboembolism in cancer patientsCihan Ay, Ingrid Pabinger
Hematology. American Society of Hematology. Education Program|February 20, 2015
Flamethrowers: blood cells and cancer thrombosis riskIngrid Pabinger, Florian Posch
Pageof 37